262 related articles for article (PubMed ID: 26375691)
41. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.
Boyer TD; Sanyal AJ; Garcia-Tsao G; Regenstein F; Rossaro L; Appenrodt B; Gülberg V; Sigal S; Bexon AS; Teuber P;
Liver Transpl; 2011 Nov; 17(11):1328-32. PubMed ID: 21837734
[TBL] [Abstract][Full Text] [Related]
42. [Renal impairment in liver diseases].
Gerbes AL; Gülberg V
Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
[TBL] [Abstract][Full Text] [Related]
43. Terlipressin and albumin combination treatment in hepatorenal syndrome.
Danalioglu A; Cakaloglu Y; Karaca C; Aksoy N; Akyuz F; Ozdil S; Demir K; Besisik F; Boztas G; Mungan Z; Kaymakoglu S; Okten A
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
[TBL] [Abstract][Full Text] [Related]
44. New treatments of hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375
[TBL] [Abstract][Full Text] [Related]
45. Hepatorenal syndrome: do the vasoconstrictors work?
Leung W; Wong F
Gastroenterol Clin North Am; 2011 Sep; 40(3):581-98. PubMed ID: 21893275
[TBL] [Abstract][Full Text] [Related]
46. Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment.
Belcher JM
Med Clin North Am; 2023 Jul; 107(4):781-792. PubMed ID: 37258014
[TBL] [Abstract][Full Text] [Related]
47. Renal dysfunction and cirrhosis.
Durand F; Olson JC; Nadim MK
Curr Opin Crit Care; 2017 Dec; 23(6):457-462. PubMed ID: 29023314
[TBL] [Abstract][Full Text] [Related]
48. [Hepatorenal syndrome].
Kürer I; Sommerer A; Puhl G; Kaisers U; Boemke W
Anaesthesist; 2006 Jan; 55(1):95-107; quiz 108-9. PubMed ID: 16372167
[TBL] [Abstract][Full Text] [Related]
49. Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice.
Angeli P; Gines P
J Hepatol; 2012 Nov; 57(5):1135-40. PubMed ID: 22749942
[TBL] [Abstract][Full Text] [Related]
50. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.
Restuccia T; Ortega R; Guevara M; Ginès P; Alessandria C; Ozdogan O; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Rodés J
J Hepatol; 2004 Jan; 40(1):140-6. PubMed ID: 14672625
[TBL] [Abstract][Full Text] [Related]
51. Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?
Sen S; Mookerjee RP; Jalan R
Gastroenterology; 2002 Dec; 123(6):2160-1. PubMed ID: 12454887
[No Abstract] [Full Text] [Related]
52. [The role of terlipressin in hepatorenal syndrome].
Forcellini S; Fabbian F
G Ital Nefrol; 2010; 27(5):469-76. PubMed ID: 20922678
[TBL] [Abstract][Full Text] [Related]
53. Hepatorenal syndrome: a review.
Testino G; Ferro C
Hepatogastroenterology; 2010; 57(102-103):1279-84. PubMed ID: 21410072
[TBL] [Abstract][Full Text] [Related]
54. Hepatorenal syndrome: current management.
Wong F
Curr Gastroenterol Rep; 2008 Feb; 10(1):22-9. PubMed ID: 18417039
[TBL] [Abstract][Full Text] [Related]
55. Pathogenesis and treatment of hepatorenal syndrome.
Arroyo V; Fernandez J; Ginès P
Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
[TBL] [Abstract][Full Text] [Related]
56. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis.
Juanola A; Solé C; Toapanta D; Ginès P; Solà E
Clin Liver Dis; 2021 May; 25(2):441-460. PubMed ID: 33838860
[TBL] [Abstract][Full Text] [Related]
57. Review article: future indications for terlipressin therapy.
Lebrec D
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():65-7; discussion 68. PubMed ID: 15335406
[TBL] [Abstract][Full Text] [Related]
58. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
59. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?
Piano S; Morando F; Fasolato S; Cavallin M; Boscato N; Boccagni P; Zanus G; Cillo U; Gatta A; Angeli P
J Hepatol; 2011 Aug; 55(2):491-6. PubMed ID: 21334405
[TBL] [Abstract][Full Text] [Related]
60. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
